drugset / Trial / NCT05865496
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the effect and safety of 611 in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).
Timeline
- Start
- 2023-06-30
- Primary completion
- 2024-05-31
- Completion
- 2024-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 611 | Unknown | 300 mg | Subcutaneous |
| Subject | 611 | Unknown | 450 mg | Subcutaneous |